In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mayne Pharma Group Ltd.

www.maynepharma.com

Latest From Mayne Pharma Group Ltd.

Mayne Reduces Resources For Generics Business

Tough operating conditions in the US retail generics markets have led Mayne Pharma to cut resources allocated to generics as it narrows its focus onto dermatology and women’s health.

Business Strategies Generic Drugs

Amneal Wins Race For US NuvaRing Rival

Amneal has become the first company to secure US approval for, and to launch, a generic alternative to Merck & Co’s top-selling, off-patent NuvaRing contraceptive device in the US. Other generics developers appear to be several months behind.

Launches Gynecology & Urology

Deal Watch: Another Delay For Roche/Spark, While FTC Ups AbbVie/Allergan Merger Scrutiny

Tender deadline for Roche acquisition of Spark pushed back to 30 October; 21.4% of Spark shares tendered so far. Vertex further diversifies with fourth deal of 2019 – an RNA-targeted collaboration with Ribometrix.

Deals M & A

Dr Reddy's Is Knocked Back On US NuvaRing And Copaxone Rivals

Dr Reddy’s has received a further CRL from the US Food and Drug Administration over its application for a generic rival to Merck Sharp & Dohme’s NuvaRing contraceptive, along with a CRL for its version of Teva’s Copaxone.

Regulation United States
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Generic Drugs
    • OTC, Consumer
  • Services
  • Therapeutic Areas
  • Cardiovascular
  • Dermatology
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • HalcyGen Pharmaceuticals Ltd.
  • FH Faulding & Co. Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Mayne Pharma Group Ltd.
  • Senior Management
  • Scott Richards, CEO, Managing Dir.
    Nick Freeman, CFO
    Ilana Stancovski, PhD, CSO
    Peter Paltoglou, Chief Dev. Officer & Head, M&A
  • Contact Info
  • Mayne Pharma Group Ltd.
    Phone: (61) 8 8209 2666
    1538 Main North Rd.
    Salisbury South, 5106
    Australia
UsernamePublicRestriction

Register